Bill Text: IL HB0068 | 2021-2022 | 102nd General Assembly | Engrossed
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Amends the Hospital Licensing Act. Provides that any hospital licensed under the Act or any hospital organized under the University of Illinois Hospital Act shall, prior to the granting of any medical staff privileges to an applicant, or renewing a current medical staff member's privileges, request of the Director of Professional Regulation information concerning the proper credentials and required certificates of the applicant. Amends the Hospital Report Card Act. Provides that the quarterly report prepared by individual hospitals shall include (1) the number of female patients who have died within the reporting period and (2) the number of female patients admitted to the hospital with a diagnosis of COVID-19 and at least one known underlying condition identified by the United States Centers for Disease Control and Prevention as a condition that increases the risk of mortality from COVID-19 who subsequently died at the hospital within the reporting period.
Spectrum: Partisan Bill (Democrat 11-0)
Status: (Passed) 2021-08-06 - Public Act . . . . . . . . . 102-0256 [HB0068 Detail]
Download: Illinois-2021-HB0068-Engrossed.html
Bill Title: Amends the Hospital Licensing Act. Provides that any hospital licensed under the Act or any hospital organized under the University of Illinois Hospital Act shall, prior to the granting of any medical staff privileges to an applicant, or renewing a current medical staff member's privileges, request of the Director of Professional Regulation information concerning the proper credentials and required certificates of the applicant. Amends the Hospital Report Card Act. Provides that the quarterly report prepared by individual hospitals shall include (1) the number of female patients who have died within the reporting period and (2) the number of female patients admitted to the hospital with a diagnosis of COVID-19 and at least one known underlying condition identified by the United States Centers for Disease Control and Prevention as a condition that increases the risk of mortality from COVID-19 who subsequently died at the hospital within the reporting period.
Spectrum: Partisan Bill (Democrat 11-0)
Status: (Passed) 2021-08-06 - Public Act . . . . . . . . . 102-0256 [HB0068 Detail]
Download: Illinois-2021-HB0068-Engrossed.html
| |||||||
| |||||||
| |||||||
1 | AN ACT concerning regulation.
| ||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||
3 | represented in the General Assembly:
| ||||||
4 | Section 5. The Hospital Licensing Act is amended by | ||||||
5 | changing Section 10.4 as follows:
| ||||||
6 | (210 ILCS 85/10.4) (from Ch. 111 1/2, par. 151.4)
| ||||||
7 | Sec. 10.4. Medical staff privileges.
| ||||||
8 | (a) Any hospital licensed under this Act or any hospital | ||||||
9 | organized under the
University of Illinois Hospital Act shall, | ||||||
10 | prior to the granting of any medical
staff privileges to an | ||||||
11 | applicant, or renewing a current medical staff member's
| ||||||
12 | privileges, request of the Director of Professional Regulation | ||||||
13 | information
concerning the licensure status , proper | ||||||
14 | credentials, required certificates, and any disciplinary | ||||||
15 | action taken against the
applicant's or medical staff member's | ||||||
16 | license, except: (1) for medical personnel who
enter a | ||||||
17 | hospital to obtain organs and tissues for transplant from a | ||||||
18 | donor in accordance with the Illinois Anatomical Gift Act; or | ||||||
19 | (2) for medical personnel who have been granted disaster | ||||||
20 | privileges pursuant to the procedures and requirements | ||||||
21 | established by rules adopted by the Department. Any hospital | ||||||
22 | and any employees of the hospital or others involved in | ||||||
23 | granting privileges who, in good faith, grant disaster |
| |||||||
| |||||||
1 | privileges pursuant to this Section to respond to an emergency | ||||||
2 | shall not, as a result of their acts or omissions, be liable | ||||||
3 | for civil damages for granting or denying disaster privileges | ||||||
4 | except in the event of willful and wanton misconduct, as that | ||||||
5 | term is defined in Section 10.2 of this Act. Individuals | ||||||
6 | granted privileges who provide care in an emergency situation, | ||||||
7 | in good faith and without direct compensation, shall not, as a | ||||||
8 | result of their acts or omissions, except for acts or | ||||||
9 | omissions involving willful and wanton misconduct, as that | ||||||
10 | term is defined in Section 10.2 of this Act, on the part of the | ||||||
11 | person, be liable for civil damages. The Director of
| ||||||
12 | Professional Regulation shall transmit, in writing and in a | ||||||
13 | timely fashion,
such information regarding the license of the | ||||||
14 | applicant or the medical staff
member, including the record of | ||||||
15 | imposition of any periods of
supervision or monitoring as a | ||||||
16 | result of alcohol or
substance abuse, as provided by Section | ||||||
17 | 23 of the Medical
Practice Act of 1987, and such information as | ||||||
18 | may have been
submitted to the Department indicating that the | ||||||
19 | application
or medical staff member has been denied, or has | ||||||
20 | surrendered,
medical staff privileges at a hospital licensed | ||||||
21 | under this
Act, or any equivalent facility in another state or
| ||||||
22 | territory of the United States. The Director of Professional | ||||||
23 | Regulation
shall define by rule the period for timely response | ||||||
24 | to such requests.
| ||||||
25 | No transmittal of information by the Director of | ||||||
26 | Professional Regulation,
under this Section shall be to other |
| |||||||
| |||||||
1 | than the president, chief
operating officer, chief | ||||||
2 | administrative officer, or chief of
the medical staff of a | ||||||
3 | hospital licensed under this Act, a
hospital organized under | ||||||
4 | the University of Illinois Hospital Act, or a hospital
| ||||||
5 | operated by the United States, or any of its | ||||||
6 | instrumentalities. The
information so transmitted shall be | ||||||
7 | afforded the same status
as is information concerning medical | ||||||
8 | studies by Part 21 of Article VIII of the
Code of Civil | ||||||
9 | Procedure, as now or hereafter amended.
| ||||||
10 | (b) All hospitals licensed under this Act, except county | ||||||
11 | hospitals as
defined in subsection (c) of Section 15-1 of the | ||||||
12 | Illinois Public Aid Code,
shall comply with, and the medical | ||||||
13 | staff bylaws of these hospitals shall
include rules consistent | ||||||
14 | with, the provisions of this Section in granting,
limiting, | ||||||
15 | renewing, or denying medical staff membership and
clinical | ||||||
16 | staff privileges. Hospitals that require medical staff members | ||||||
17 | to
possess
faculty status with a specific institution of | ||||||
18 | higher education are not required
to comply with subsection | ||||||
19 | (1) below when the physician does not possess faculty
status.
| ||||||
20 | (1) Minimum procedures for
pre-applicants and | ||||||
21 | applicants for medical staff
membership shall include the | ||||||
22 | following:
| ||||||
23 | (A) Written procedures relating to the acceptance | ||||||
24 | and processing of
pre-applicants or applicants for | ||||||
25 | medical staff membership, which should be
contained in
| ||||||
26 | medical staff bylaws.
|
| |||||||
| |||||||
1 | (B) Written procedures to be followed in | ||||||
2 | determining
a pre-applicant's or
an applicant's
| ||||||
3 | qualifications for being granted medical staff | ||||||
4 | membership and privileges.
| ||||||
5 | (C) Written criteria to be followed in evaluating
| ||||||
6 | a pre-applicant's or
an applicant's
qualifications.
| ||||||
7 | (D) An evaluation of
a pre-applicant's or
an | ||||||
8 | applicant's current health status and current
license | ||||||
9 | status in Illinois.
| ||||||
10 | (E) A written response to each
pre-applicant or
| ||||||
11 | applicant that explains the reason or
reasons for any | ||||||
12 | adverse decision (including all reasons based in whole | ||||||
13 | or
in part on the applicant's medical qualifications | ||||||
14 | or any other basis,
including economic factors).
| ||||||
15 | (2) Minimum procedures with respect to medical staff | ||||||
16 | and clinical
privilege determinations concerning current | ||||||
17 | members of the medical staff shall
include the following:
| ||||||
18 | (A) A written notice of an adverse decision.
| ||||||
19 | (B) An explanation of the reasons for an adverse | ||||||
20 | decision including all
reasons based on the quality of | ||||||
21 | medical care or any other basis, including
economic | ||||||
22 | factors.
| ||||||
23 | (C) A statement of the medical staff member's | ||||||
24 | right to request a fair
hearing on the adverse | ||||||
25 | decision before a hearing panel whose membership is
| ||||||
26 | mutually agreed upon by the medical staff and the |
| |||||||
| |||||||
1 | hospital governing board. The
hearing panel shall have | ||||||
2 | independent authority to recommend action to the
| ||||||
3 | hospital governing board. Upon the request of the | ||||||
4 | medical staff member or the
hospital governing board, | ||||||
5 | the hearing panel shall make findings concerning the
| ||||||
6 | nature of each basis for any adverse decision | ||||||
7 | recommended to and accepted by
the hospital governing | ||||||
8 | board.
| ||||||
9 | (i) Nothing in this subparagraph (C) limits a | ||||||
10 | hospital's or medical
staff's right to summarily | ||||||
11 | suspend, without a prior hearing, a person's | ||||||
12 | medical
staff membership or clinical privileges if | ||||||
13 | the continuation of practice of a
medical staff | ||||||
14 | member constitutes an immediate danger to the | ||||||
15 | public, including
patients, visitors, and hospital | ||||||
16 | employees and staff. In the event that a hospital | ||||||
17 | or the medical staff imposes a summary suspension, | ||||||
18 | the Medical Executive Committee, or other | ||||||
19 | comparable governance committee of the medical | ||||||
20 | staff as specified in the bylaws, must meet as | ||||||
21 | soon as is reasonably possible to review the | ||||||
22 | suspension and to recommend whether it should be | ||||||
23 | affirmed, lifted, expunged, or modified if the | ||||||
24 | suspended physician requests such review. A | ||||||
25 | summary suspension may not be implemented unless | ||||||
26 | there is actual documentation or other reliable |
| |||||||
| |||||||
1 | information that an immediate danger exists. This | ||||||
2 | documentation or information must be available at | ||||||
3 | the time the summary suspension decision is made | ||||||
4 | and when the decision is reviewed by the Medical | ||||||
5 | Executive Committee. If the Medical Executive | ||||||
6 | Committee recommends that the summary suspension | ||||||
7 | should be lifted, expunged, or modified, this | ||||||
8 | recommendation must be reviewed and considered by | ||||||
9 | the hospital governing board, or a committee of | ||||||
10 | the board, on an expedited basis. Nothing in this | ||||||
11 | subparagraph (C) shall affect the requirement that | ||||||
12 | any requested hearing must be commenced within 15 | ||||||
13 | days after the summary suspension and completed | ||||||
14 | without delay unless otherwise agreed to by the | ||||||
15 | parties. A fair hearing shall be
commenced within | ||||||
16 | 15 days after the suspension and completed without | ||||||
17 | delay, except that when the medical staff member's | ||||||
18 | license to practice has been suspended or revoked | ||||||
19 | by the State's licensing authority, no hearing | ||||||
20 | shall be necessary.
| ||||||
21 | (ii) Nothing in this subparagraph (C) limits a | ||||||
22 | medical staff's right
to permit, in the medical | ||||||
23 | staff bylaws, summary suspension of membership or
| ||||||
24 | clinical privileges in designated administrative | ||||||
25 | circumstances as specifically
approved by the | ||||||
26 | medical staff. This bylaw provision must |
| |||||||
| |||||||
1 | specifically describe
both the administrative | ||||||
2 | circumstance that can result in a summary | ||||||
3 | suspension
and the length of the summary | ||||||
4 | suspension. The opportunity for a fair hearing is
| ||||||
5 | required for any administrative summary | ||||||
6 | suspension. Any requested hearing must
be | ||||||
7 | commenced within 15 days after the summary | ||||||
8 | suspension and completed without
delay. Adverse | ||||||
9 | decisions other than suspension or other | ||||||
10 | restrictions on the
treatment or admission of | ||||||
11 | patients may be imposed summarily and without a
| ||||||
12 | hearing under designated administrative | ||||||
13 | circumstances as specifically provided
for in the | ||||||
14 | medical staff bylaws as approved by the medical | ||||||
15 | staff.
| ||||||
16 | (iii) If a hospital exercises its option to | ||||||
17 | enter into an exclusive
contract and that contract | ||||||
18 | results in the total or partial termination or
| ||||||
19 | reduction of medical staff membership or clinical | ||||||
20 | privileges of a current
medical staff member, the | ||||||
21 | hospital shall provide the affected medical staff
| ||||||
22 | member 60 days prior notice of the effect on his or | ||||||
23 | her medical staff
membership or privileges. An | ||||||
24 | affected medical staff member desiring a hearing
| ||||||
25 | under subparagraph (C) of this paragraph (2) must | ||||||
26 | request the hearing within 14
days after the date |
| |||||||
| |||||||
1 | he or she is so notified. The requested hearing | ||||||
2 | shall be
commenced and completed (with a report | ||||||
3 | and recommendation to the affected
medical staff | ||||||
4 | member, hospital governing board, and medical | ||||||
5 | staff) within 30
days after the date of the | ||||||
6 | medical staff member's request. If agreed upon by
| ||||||
7 | both the medical staff and the hospital governing | ||||||
8 | board, the medical staff
bylaws may provide for | ||||||
9 | longer time periods.
| ||||||
10 | (C-5) All peer review used for the purpose of | ||||||
11 | credentialing, privileging, disciplinary action, or | ||||||
12 | other recommendations affecting medical staff | ||||||
13 | membership or exercise of clinical privileges, whether | ||||||
14 | relying in whole or in part on internal or external | ||||||
15 | reviews, shall be conducted in accordance with the | ||||||
16 | medical staff bylaws and applicable rules, | ||||||
17 | regulations, or policies of the medical staff. If | ||||||
18 | external review is obtained, any adverse report | ||||||
19 | utilized shall be in writing and shall be made part of | ||||||
20 | the internal peer review process under the bylaws. The | ||||||
21 | report shall also be shared with a medical staff peer | ||||||
22 | review committee and the individual under review. If | ||||||
23 | the medical staff peer review committee or the | ||||||
24 | individual under review prepares a written response to | ||||||
25 | the report of the external peer review within 30 days | ||||||
26 | after receiving such report, the governing board shall |
| |||||||
| |||||||
1 | consider the response prior to the implementation of | ||||||
2 | any final actions by the governing board which may | ||||||
3 | affect the individual's medical staff membership or | ||||||
4 | clinical privileges. Any peer review that involves | ||||||
5 | willful or wanton misconduct shall be subject to civil | ||||||
6 | damages as provided for under Section 10.2 of this | ||||||
7 | Act.
| ||||||
8 | (D) A statement of the member's right to inspect | ||||||
9 | all pertinent
information in the hospital's possession | ||||||
10 | with respect to the decision.
| ||||||
11 | (E) A statement of the member's right to present | ||||||
12 | witnesses and other
evidence at the hearing on the | ||||||
13 | decision.
| ||||||
14 | (E-5) The right to be represented by a personal | ||||||
15 | attorney.
| ||||||
16 | (F) A written notice and written explanation of | ||||||
17 | the decision resulting
from the hearing.
| ||||||
18 | (F-5) A written notice of a final adverse decision | ||||||
19 | by a hospital
governing board.
| ||||||
20 | (G) Notice given 15 days before implementation of | ||||||
21 | an adverse medical
staff membership or clinical | ||||||
22 | privileges decision based substantially on
economic | ||||||
23 | factors. This notice shall be given after the medical | ||||||
24 | staff member
exhausts all applicable procedures under | ||||||
25 | this Section, including item (iii) of
subparagraph (C) | ||||||
26 | of this paragraph (2), and under the medical staff |
| |||||||
| |||||||
1 | bylaws in
order to allow sufficient time for the | ||||||
2 | orderly provision of patient care.
| ||||||
3 | (H) Nothing in this paragraph (2) of this | ||||||
4 | subsection (b) limits a
medical staff member's right | ||||||
5 | to waive, in writing, the rights provided in
| ||||||
6 | subparagraphs (A) through (G) of this paragraph (2) of | ||||||
7 | this subsection (b) upon
being granted the written | ||||||
8 | exclusive right to provide particular services at a
| ||||||
9 | hospital, either individually or as a member of a | ||||||
10 | group. If an exclusive
contract is signed by a | ||||||
11 | representative of a group of physicians, a waiver
| ||||||
12 | contained in the contract shall apply to all members | ||||||
13 | of the group unless stated
otherwise in the contract.
| ||||||
14 | (3) Every adverse medical staff membership and | ||||||
15 | clinical privilege decision
based substantially on | ||||||
16 | economic factors shall be reported to the Hospital
| ||||||
17 | Licensing Board before the decision takes effect. These | ||||||
18 | reports shall not be
disclosed in any form that reveals | ||||||
19 | the identity of any hospital or physician.
These reports | ||||||
20 | shall be utilized to study the effects that hospital | ||||||
21 | medical
staff membership and clinical privilege decisions | ||||||
22 | based upon economic factors
have on access to care and the | ||||||
23 | availability of physician services. The
Hospital Licensing | ||||||
24 | Board shall submit an initial study to the Governor and | ||||||
25 | the
General Assembly by January 1, 1996, and subsequent | ||||||
26 | reports shall be submitted
periodically thereafter.
|
| |||||||
| |||||||
1 | (4) As used in this Section:
| ||||||
2 | "Adverse decision" means a decision reducing, | ||||||
3 | restricting, suspending,
revoking, denying, or not | ||||||
4 | renewing medical staff membership or clinical
privileges.
| ||||||
5 | "Economic factor" means any information or reasons for | ||||||
6 | decisions unrelated
to quality of care or professional | ||||||
7 | competency.
| ||||||
8 | "Pre-applicant" means a physician licensed to practice | ||||||
9 | medicine in all
its
branches who requests an application | ||||||
10 | for medical staff membership or
privileges.
| ||||||
11 | "Privilege" means permission to provide
medical or | ||||||
12 | other patient care services and permission to use hospital
| ||||||
13 | resources, including equipment, facilities and personnel | ||||||
14 | that are necessary to
effectively provide medical or other | ||||||
15 | patient care services. This definition
shall not be | ||||||
16 | construed to
require a hospital to acquire additional | ||||||
17 | equipment, facilities, or personnel to
accommodate the | ||||||
18 | granting of privileges.
| ||||||
19 | (5) Any amendment to medical staff bylaws required | ||||||
20 | because of
this amendatory Act of the 91st General | ||||||
21 | Assembly shall be adopted on or
before July 1, 2001.
| ||||||
22 | (c) All hospitals shall consult with the medical staff | ||||||
23 | prior to closing
membership in the entire or any portion of the | ||||||
24 | medical staff or a department.
If
the hospital closes | ||||||
25 | membership in the medical staff, any portion of the medical
| ||||||
26 | staff, or the department over the objections of the medical |
| |||||||
| |||||||
1 | staff, then the
hospital
shall provide a detailed written | ||||||
2 | explanation for the decision to the medical
staff
10 days | ||||||
3 | prior to the effective date of any closure. No applications | ||||||
4 | need to be
provided when membership in the medical staff or any | ||||||
5 | relevant portion of the
medical staff is closed.
| ||||||
6 | (Source: P.A. 96-445, eff. 8-14-09; 97-1006, eff. 8-17-12.)
| ||||||
7 | Section 10. The Hospital Report Card Act is amended by | ||||||
8 | changing Section 25 as follows:
| ||||||
9 | (210 ILCS 86/25)
| ||||||
10 | Sec. 25. Hospital reports.
| ||||||
11 | (a) Individual hospitals shall prepare a quarterly report | ||||||
12 | including all of
the
following:
| ||||||
13 | (1) Nursing hours per patient day, average daily | ||||||
14 | census, and average daily
hours worked
for each clinical | ||||||
15 | service area.
| ||||||
16 | (2) Infection-related measures for the facility for | ||||||
17 | the specific clinical
procedures
and devices determined by | ||||||
18 | the Department by rule under 2 or more of the following | ||||||
19 | categories:
| ||||||
20 | (A) Surgical procedure outcome measures. | ||||||
21 | (B) Surgical procedure infection control process | ||||||
22 | measures.
| ||||||
23 | (C)
Outcome or process measures related to | ||||||
24 | ventilator-associated pneumonia.
|
| |||||||
| |||||||
1 | (D) Central vascular catheter-related bloodstream | ||||||
2 | infection rates in designated critical care units.
| ||||||
3 | (3) Information required under paragraph (4) of | ||||||
4 | Section 2310-312 of the Department of Public Health Powers | ||||||
5 | and Duties Law of the
Civil Administrative Code of | ||||||
6 | Illinois.
| ||||||
7 | (4) Additional infection measures mandated by the | ||||||
8 | Centers for Medicare and Medicaid Services that are | ||||||
9 | reported by hospitals to the Centers for Disease Control | ||||||
10 | and Prevention's National Healthcare Safety Network | ||||||
11 | surveillance system, or its successor, and deemed relevant | ||||||
12 | to patient safety by the Department. | ||||||
13 | (5) Each instance of preterm birth and infant | ||||||
14 | mortality within the reporting period, including the | ||||||
15 | racial and ethnic information of the mothers of those | ||||||
16 | infants. | ||||||
17 | (6) Each instance of maternal mortality within the | ||||||
18 | reporting period, including the racial and ethnic | ||||||
19 | information of those mothers. | ||||||
20 | (7) The number of female patients who have died within | ||||||
21 | the reporting period. | ||||||
22 | (8) The number of female patients admitted to the | ||||||
23 | hospital with a diagnosis of COVID-19 and at least one | ||||||
24 | known underlying condition identified by the United States | ||||||
25 | Centers for Disease Control and Prevention as a condition | ||||||
26 | that increases the risk of mortality from COVID-19 who |
| |||||||
| |||||||
1 | subsequently died at the hospital within the reporting | ||||||
2 | period. | ||||||
3 | The infection-related measures developed by the Department | ||||||
4 | shall be based upon measures and methods developed by the | ||||||
5 | Centers for Disease Control and Prevention, the Centers for | ||||||
6 | Medicare and Medicaid Services, the Agency for Healthcare | ||||||
7 | Research and Quality, the Joint Commission on Accreditation of | ||||||
8 | Healthcare Organizations, or the National Quality Forum. The | ||||||
9 | Department may align the infection-related measures with the | ||||||
10 | measures and methods developed by the Centers for Disease | ||||||
11 | Control and Prevention, the Centers for Medicare and Medicaid | ||||||
12 | Services, the Agency for Healthcare Research and Quality, the | ||||||
13 | Joint Commission on Accreditation of Healthcare Organizations, | ||||||
14 | and the National Quality Forum by adding reporting measures | ||||||
15 | based on national health care strategies and measures deemed | ||||||
16 | scientifically reliable and valid for public reporting. The | ||||||
17 | Department shall receive approval from the State Board of | ||||||
18 | Health to retire measures deemed no longer scientifically | ||||||
19 | valid or valuable for informing quality improvement or | ||||||
20 | infection prevention efforts. The Department shall notify the | ||||||
21 | Chairs and Minority Spokespersons of the House Human Services | ||||||
22 | Committee and the Senate Public Health Committee of its intent | ||||||
23 | to have the State Board of Health take action to retire | ||||||
24 | measures no later than 7 business days before the meeting of | ||||||
25 | the State Board of Health. | ||||||
26 | The Department shall include interpretive guidelines for |
| |||||||
| |||||||
1 | infection-related indicators and, when available, shall | ||||||
2 | include relevant benchmark information published by national | ||||||
3 | organizations.
| ||||||
4 | The Department shall collect the information reported | ||||||
5 | under paragraphs (5) and (6) and shall use it to illustrate the | ||||||
6 | disparity of those occurrences across different racial and | ||||||
7 | ethnic groups. | ||||||
8 | (b) Individual hospitals shall prepare annual reports | ||||||
9 | including vacancy and
turnover rates
for licensed nurses per | ||||||
10 | clinical service area.
| ||||||
11 | (c) None of the information the Department discloses to | ||||||
12 | the public may be
made
available
in any form or fashion unless | ||||||
13 | the information has been reviewed, adjusted, and
validated
| ||||||
14 | according to the following process:
| ||||||
15 | (1) The Department shall organize an advisory | ||||||
16 | committee, including
representatives
from the Department, | ||||||
17 | public and private hospitals, direct care nursing staff,
| ||||||
18 | physicians,
academic researchers, consumers, health | ||||||
19 | insurance companies, organized labor,
and
organizations | ||||||
20 | representing hospitals and physicians. The advisory | ||||||
21 | committee
must be
meaningfully involved in the development | ||||||
22 | of all aspects of the Department's
methodology
for | ||||||
23 | collecting, analyzing, and disclosing the information | ||||||
24 | collected under this
Act, including
collection methods, | ||||||
25 | formatting, and methods and means for release and
| ||||||
26 | dissemination.
|
| |||||||
| |||||||
1 | (2) The entire methodology for collecting and | ||||||
2 | analyzing the data shall be
disclosed
to all
relevant | ||||||
3 | organizations and to all hospitals that are the subject of | ||||||
4 | any
information to be made
available to the public before | ||||||
5 | any public disclosure of such information.
| ||||||
6 | (3) Data collection and analytical methodologies shall | ||||||
7 | be used that meet
accepted
standards of validity and | ||||||
8 | reliability before any information is made available
to | ||||||
9 | the public.
| ||||||
10 | (4) The limitations of the data sources and analytic | ||||||
11 | methodologies used to
develop
comparative hospital | ||||||
12 | information shall be clearly identified and acknowledged,
| ||||||
13 | including but not
limited to the appropriate and | ||||||
14 | inappropriate uses of the data.
| ||||||
15 | (5) To the greatest extent possible, comparative | ||||||
16 | hospital information
initiatives shall
use standard-based | ||||||
17 | norms derived from widely accepted provider-developed
| ||||||
18 | practice
guidelines.
| ||||||
19 | (6) Comparative hospital information and other | ||||||
20 | information that the
Department
has
compiled regarding | ||||||
21 | hospitals shall be shared with the hospitals under review
| ||||||
22 | prior to
public
dissemination of such information and | ||||||
23 | these hospitals have 30 days to make
corrections and
to | ||||||
24 | add helpful explanatory comments about the information | ||||||
25 | before the
publication.
| ||||||
26 | (7) Comparisons among hospitals shall adjust for |
| |||||||
| |||||||
1 | patient case mix and
other
relevant
risk factors and | ||||||
2 | control for provider peer groups, when appropriate.
| ||||||
3 | (8) Effective safeguards to protect against the | ||||||
4 | unauthorized use or
disclosure
of
hospital information | ||||||
5 | shall be developed and implemented.
| ||||||
6 | (9) Effective safeguards to protect against the | ||||||
7 | dissemination of
inconsistent,
incomplete, invalid, | ||||||
8 | inaccurate, or subjective hospital data shall be developed
| ||||||
9 | and
implemented.
| ||||||
10 | (10) The quality and accuracy of hospital information | ||||||
11 | reported under this
Act
and its
data collection, analysis, | ||||||
12 | and dissemination methodologies shall be evaluated
| ||||||
13 | regularly.
| ||||||
14 | (11) Only the most basic identifying information from | ||||||
15 | mandatory reports
shall be
used, and
information | ||||||
16 | identifying a patient, employee, or licensed professional
| ||||||
17 | shall not be released.
None of the information the | ||||||
18 | Department discloses to the public under this Act
may be | ||||||
19 | used to
establish a standard of care in a private civil | ||||||
20 | action.
| ||||||
21 | (d) Quarterly reports shall be submitted, in a format set | ||||||
22 | forth in rules
adopted
by the
Department, to the Department by | ||||||
23 | April 30, July 31, October 31, and January 31
each year
for the | ||||||
24 | previous quarter. Data in quarterly reports must cover a | ||||||
25 | period ending
not earlier than
one month prior to submission | ||||||
26 | of the report. Annual reports shall be submitted
by December
|
| |||||||
| |||||||
1 | 31 in a format set forth in rules adopted by the Department to | ||||||
2 | the Department.
All reports
shall be made available to the | ||||||
3 | public on-site and through the Department.
| ||||||
4 | (e) If the hospital is a division or subsidiary of another | ||||||
5 | entity that owns
or
operates other
hospitals or related | ||||||
6 | organizations, the annual public disclosure report shall
be | ||||||
7 | for the specific
division or subsidiary and not for the other | ||||||
8 | entity.
| ||||||
9 | (f) The Department shall disclose information under this | ||||||
10 | Section in
accordance with provisions for inspection and | ||||||
11 | copying of public records
required by the Freedom of
| ||||||
12 | Information Act provided that such information satisfies the | ||||||
13 | provisions of
subsection (c) of this Section.
| ||||||
14 | (g) Notwithstanding any other provision of law, under no | ||||||
15 | circumstances shall
the
Department disclose information | ||||||
16 | obtained from a hospital that is confidential
under Part 21
of | ||||||
17 | Article VIII of the Code of Civil Procedure.
| ||||||
18 | (h) No hospital report or Department disclosure may | ||||||
19 | contain information
identifying a patient, employee, or | ||||||
20 | licensed professional.
| ||||||
21 | (Source: P.A. 101-446, eff. 8-23-19.)
|